Regulation of cell cycles is of key importance in human papillomavirus (HPV) - Associated cervical carcinogenesis

Sao Paulo Medical Journal

Volumn 121, Issue 3, 2003, Pages 128-132

  Fernandes Brenna, Sylvia Michelina ^a   Syrjänen, Kari Juhani ^b  

^a HOSPITAL MATERNIDADE LEONOR MENDES DE BARROS   (Brazil)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Cell cycle; Cervical cancers; Histone deacetylase; Human papillomavirus; Tumor suppressor genes

Indexed keywords

DOUBLE STRANDED DNA; HISTONE DEACETYLASE; REGULATOR PROTEIN; TUMOR SUPPRESSOR PROTEIN; VIRUS PROTEIN;

CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER REGRESSION; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL FUNCTION; CELL GROWTH; CELL IMMORTALIZATION; CELL TRANSFORMATION; CONDYLOMA; FEMALE; FOLLOW UP; GENE FUNCTION; GENE IDENTIFICATION; GENETIC DISORDER; GROWTH REGULATION; HUMAN; MORBIDITY; MORTALITY; PERSISTENT VIRUS INFECTION; PROTEIN PROTEIN INTERACTION; REVIEW; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; VIRUS REPLICATION; WART VIRUS;

EID: 0041886627     PISSN: 15163180     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1516-31802003000300009     Document Type: Review

References (15)

1. Kastan MB. Molecular biology of cancer: the cell cycle. In: De Vita VT, Helman S, Rosenberg S, editors. Cancer: principles & practice of oncology. 5th ed. Phildephia: Lippicott-Raven; 1997. p. 121-33.
2. Syrjänen K. Human papillomaviruses in pathogenesis of lower genital tract neoplasia. In: Singer A, Monaghan JM, editors. Lower genital tract precancer. 2nd ed. Oxford: Blackwell Science; 2000. p.15-33.
3. Syrjänen SM, Syrjänen KJ. New concepts on the role of human papillomavirus in cell cycle regulation. Ann Med 1999;31(3):175-87.
4. dos Santos Oliveira L do H, Fernandez A de P, Xavier BL, Machado-Rodrigues E de V, Cavalcanti SM. Analysis of the p53 gene and papillomavirus detection smears from cervical lesions. Sao Paulo Med J 2002;120(1):20-2.
5. IARC database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualization tools. 2nd ed, Lyon, France; 2001. Available from:http://www.iarc.fr/p53
6. Brenna SM, Zeferino LC, Pinto GA, et al. P53 expression as a predictor of recurrence in cervical squamous cell carcinoma. Int J Gynecol Cancer 2002;12(3):299-303.
7. Makni H, Franco EL, Kaiano J, et al. P53 polymorphism in codon 72 and risk of papillomavirus-induced cervical cancer: effect of inter-laboratory variation. Int J Cancer 2000;87(4):528-33.
8. Syrjänen KJ. Genital human papillomavirus infection and their association with squamous cell cancer: reappraisal of the morphologic, epidemiologic and DNA data. In: Fenoglio-Preiser CM, Wolff M, Rilke F, editors. Progress in surgical pathology. USA: Fields & Wood; 1992. p.217-39.
9. Syrjänen KJ, Syrjänen SM. Molecular biology of papillomaviruses. In: Syrjänen KJ, Syrjänen SM, editors. Papillomavirus infections in human pathology. New York: John Wiley & Sons; 2000. p.11-51.
10. Southern SA, Herrington CS. Disruptions of cell cycle control by human papillomavirus with special reference to cervical carcinoma. Int J Gynecol Cancer 2000;10(4):263-74.
11. Murta EF, Souza MA, Araújo Júnior E, Adad SJ. Incidence of Gardnerella vaginalis, Candida sp. and human papillomavirus in cytological smears. São Paulo Med J 2000;118(4):105-8.
12. Nguyen DX, Westbrook TF, McCance DJ. Human papillomavirus type 16 E7 maintains elevated levels of the cdc25A tyrosine phosphatase during deregulation of cell cycle arrest. J Virol 2002;76(2):619-32.
13. Juan LJ, Shia WJ, Chen MH, et al. Histone deacetylases specifically down-regulate p53-dependent gene activation. J Biol Chem 2000;275(27):20436-43.
14. Ferenczy A, Franco E. Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncol 2002;3(1):11-6.
15. Ferenczy A, Franco E. Cervical-cancer screening beyond the year 2000. Lancet Oncol 2001;2(1):27-32.